Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)

The Biomedical Technology Optimization and Dissemination Center program is administered by the National Institute of General Medical Sciences within the U.S. Department of Health and Human Services through the National Institutes of Health. This funding opportunity supports advanced biomedical research infrastructure by enabling centers that specialize in optimizing and broadly disseminating technologies that have already demonstrated feasibility in laboratory environments. The program aligns with the broader mission of NIGMS to advance fundamental understanding of biological systems and to support research that underpins improvements in disease diagnosis, treatment, and prevention across multiple organ systems and clinical contexts. The primary objective of this program is to fund centers that can take late-stage biomedical technologies and refine them for broader usability across the research community. These centers are expected to operate at the forefront of their respective technological domains, ensuring that innovations move beyond specialized expert environments and become accessible to a wider base of investigators. Technologies supported may include tools in analytical biochemistry, molecular biology, computational modeling, imaging, spatial omics, and related fields. The program emphasizes both technical optimization and sustainable dissemination strategies, ensuring long-term impact beyond the funding period. Funded centers must be structured around three integrated components: Technology Optimization Projects, Driving Biomedical Projects, and Community Engagement. Technology Optimization Projects form the core and focus on refining technologies to enhance robustness and usability. Driving Biomedical Projects act as real-world testing environments where these technologies are applied and refined through collaboration with external investigators. Community Engagement activities ensure that optimized technologies are disseminated widely through training, publications, workshops, and partnerships, including potential commercialization pathways. Centers are also required to maintain a strong web presence and provide accessible training resources. Funding allows for direct costs up to 850000 dollars per year, excluding certain equipment and consortium costs, with a maximum project period of five years. Additional funds for specialized equipment may be requested if justified. The program does not require cost sharing or matching contributions. However, strict rules apply to allowable costs, including prohibitions on funding external collaborator research activities, trainee stipends, and certain travel expenses. Centers must also demonstrate a clear path to sustainability and independence from continued funding. Eligible applicants include a broad range of U.S.-based institutions such as public and private higher education institutions, nonprofits, for-profit organizations, and government entities at various levels. Foreign organizations are not eligible to apply, although limited collaboration without funding is permitted. Applicants must complete required federal registrations, including SAM, Grants.gov, and eRA Commons, and ensure all principal investigators are properly registered. Each principal investigator must commit a minimum level of effort to the project. Applications must be submitted through approved federal systems such as Grants.gov or the NIH ASSIST platform. The application requires detailed components including research strategy sections, budget justifications, data management plans, and descriptions of the center structure and activities. Applications are evaluated through NIH peer review processes based on criteria such as significance, innovation, investigator qualifications, approach, and environment. Additional emphasis is placed on the effectiveness of dissemination strategies and the integration of the center components. The application timeline includes multiple recurring submission cycles per year, with deadlines in September, January, and May through 2029. Applications must be submitted by 5:00 PM local time on the due date. Review and award timelines follow standard NIH cycles, with scientific review occurring several months after submission and earliest project start dates approximately 9 to 12 months later. Applicants are encouraged to consult with program staff prior to submission to ensure alignment with program goals and requirements.

Emphasize integration of technology optimization with real-world biomedical applications and strong dissemination strategies; demonstrate broad impact and sustainability